Skip to content

Clinical Research on the Intervention of Lei-Huo Moxibustion on Cancer-Related Fatigue in Patients with Qi Stagnation and Blood Stasis Type of Colorectal Cancer Undergoing Chemotherapy

Clinical Research on the Intervention of Lei-Huo Moxibustion on Cancer-Related Fatigue in Patients with Qi Stagnation and Blood Stasis Type of Colorectal Cancer Undergoing Chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000305
Enrollment
Unknown
Registered
2025-02-17
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Experimental group:Thunder fire moxibustion
Control group:Routine care for cancer-related fatigue

Sponsors

Nanjing Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for chemotherapy patients with colorectal cancer with qi stagnation and blood stasis with cancer-induced fatigue; (2) Patients who are receiving chemotherapy regimens for the first time and have 2 or more chemotherapy cycle treatment plans; (3) Piper Fatigue Revised Scale score > 3 points i.e. moderate and severe fatigue; (4) Age= 18 years old; (5) Clear consciousness and ability to accurately express moxibustion feelings; (6) Voluntary participation and signed informed consent. If the above criteria are met at the same time they will be included in this test.

Exclusion criteria

Exclusion criteria: (1) Patients with serious diseases such as heart liver kidney and endocrine system; (2) Local skin ulceration is not suitable for thunder fire moxibustion and those who are allergic to thunder fire moxibustion; (3) Patients with mental illness and cognitive impairment and unclear language expression; (4) pregnant or lactating patients; (5) Patients who participate in other clinical trials at the same time; (6) Patients with poor compliance and inability to cooperate. Any of the above conditions cannot be included in this trial.

Design outcomes

Primary

MeasureTime frame
Degree of fatigue;

Secondary

MeasureTime frame
TCM Syndrome Points;Biochemical indexes (blood count);quality of life;Sleep quality;

Countries

china

Contacts

Public ContactHong Yanyan

Nanjing Hospital of Chinese Medicine

fsyy00210@njucm.edu.cn18951755277

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 17, 2026